Rating
Buy
Price target
NT$3,500
Previous
—
Implied upside
—
Aletheia Capital on TSMC · target history
Apr 10, 2026 · NT$3,000 · Buy Jun 16, 2026 · NT$3,500 · Buy · this note

Aletheia Capital analyst Stefan Chang raised the price target on TSMC (2330:TT) (NYSE: TSM) to NT$3,500.00 while maintaining a Buy rating.

“After our recent field trip to all TSMC’s new fabs in Taiwan, we now believe TSMC’s new advanced nodes capacity expansion will be 70kwpm, 150kwpm, and 170kwpm in 2026/27/28E.

This suggests TSMC’s WFE can potentially double YoY in 2027E, while 2028E will see double digit growth.

As for the back-end, we believe TSMC will focus more on CoWoS in the next 12 months, while SoIC and CoPoS will be more of a 2H27E/2028E story.

Should TSMC be able to fill up all new capacity, its revenue and earnings growth should accelerate in 2028E following a 30%+ CAGR in 2024-2027E, which the market has currently underestimated.

For the near-term, TSMC is likely to top its 2Q26E revenue guidance and beat on margins.

We reiterate BUY for TSMC and raise our TP to TWD3,500/$700 for the local shares and the ADR, based on 20x/25x average 2027/28E P/E.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.